✦ LIBER ✦

Phase I dose-escalation and pharmacokinetic study (TED 11576) of cabazitaxel in Japanese patients with castration-resistant prostate cancer

✍ Scribed by Mukai, Hirofumi; Takahashi, Shunji; Nozawa, Masahiro; Onozawa, Yusuke; Miyazaki, Jun; Ohno, Keiji; Suzuki, Kazuhiro

Book ID: 121560492
Publisher: Springer
Year: 2014
Tongue: English
Weight: 295 KB
Volume: 73
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-014-2394-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I pharmacokinetic and biodistribut

Phase I pharmacokinetic and biodistribution study with escalating doses of223Ra-dichloride in men with castration-resistant metastatic prostate cancer

✍ Carrasquillo, Jorge A.; OâDonoghue, Joseph A.; Pandit-Taskar, Neeta; Humm, Joh 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 426 KB

Open-label, phase I dose-escalation stud

Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer

✍ Corcoran, N M; Hovens, C M; Michael, M; Rosenthal, M A; Costello, A J 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 333 KB

A phase I escalating single-dose and wee

A phase I escalating single-dose and weekly fixed-dose study of cetuximab pharmacokinetics in Japanese patients with solid tumors

✍ Kuniaki Shirao; Takayuki Yoshino; Narikazu Boku; Ken Kato; Tetsuya Hamaguchi; Hi 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 342 KB

Phase I Dose-Escalation and Pharmacokine

Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors

✍ Demetri, G. D.; Lo Russo, P.; MacPherson, I. R.J.; Wang, D.; Morgan, J. A.; Brun 📂 Article 📅 2009 🏛 American Association for Cancer Research 🌐 English ⚖ 238 KB

421 POSTER Phase I dose escalation and p

421 POSTER Phase I dose escalation and pharmacokinetic study of oral enzastaurin in Japanese patients with advanced solid tumour

✍ T. Mukohara; S. Nagai; Y. Nambu; K. Yoshizawa; H. Minami 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Open-label, clinical phase I studies of

Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer

✍ Häggman, M; Ahlgren, G; Nordle, Ö; Björk, A; Damber, J-E; Bratt, O 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 371 KB